Journals / Anestezi Dergisi / 2001 / Cilt: 9 - Sayı: 1

Guillain Barre syndrome and immonoadsorption plasmapheresis (Case report)

Guillain Barre sendromu ve immunoadsorbsiyon plazmaferez (Olgu sunumu)2

Pages
62–66
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Plasmapheresis is recommended for patients with severe weakness, which may include inability to walk and difficulty breathing or other signs of bulbar insufficiency, including loss of gag reflex or difficulty in swallowing.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Guillain Barre syndrome (GBS) is an acute demyelinating polyradiculoneuropathy characterized by bilateral upper and lower extremity muscle weakness, loss of reflexes, and variable degrees of sensorial loss.
📊
Key Findings & Data:Plasmapheresis is recommended for patients with severe weakness, which may include inability to walk and difficulty breathing or other signs of bulbar insufficiency, including loss of gag reflex or difficulty in swallowing.
💡
Conclusion & Impact:In this report, we discusses the care in intensive care unit and immunoadsorption plasmapheresis in treatment of patients with GBS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Guillain-Barre sendromu · Erişkin · Plazmaferez

Abstract

Guillain Barre syndrome (GBS) is an acute demyelinating polyradiculoneuropathy characterized by bilateral upper and lower extremity muscle weakness, loss of reflexes, and variable degrees of sensorial loss. Plasmapheresis is recommended for patients with severe weakness, which may include inability to walk and difficulty breathing or other signs of bulbar insufficiency, including loss of gag reflex or difficulty in swallowing. In this report, we discusses the care in intensive care unit and immunoadsorption plasmapheresis in treatment of patients with GBS.

Özet

Guillain Barre sendromu (GBS); üst ve alt ekstremitelerde çift taraflı kas güçsüzlüğü, refleks ve değişik derecelerde sensoriyal kayıpla karakterize akut demiyelizan bir poliradikülonöropatidir. Plazmaferez, yürüyememe ve solunum yetersizliği gibi şiddetli kas güçsüzlüğü olan veya yutkunma refleksinin kaybı ve yutma güçsüzlüğü gibi diğer bulber yetersizlik bulguları gösteren CBS'li olgularda tavsiye edilmektedir. Biz bu sunumuzda; Guillain Barre sendromlu olguların tedavisinde immunoadsorbsiyon plazmaferez ve yoğun bakım servislerinde uygulanması gereken destek tedavisini tartıştık.

🔖

Cite This Article

YOSUNKAYA, A., TUNCER, S., TAVLAN, A., SARKILAR, G., ÖKESLİ, S. (2001). Guillain Barre syndrome and immonoadsorption plasmapheresis (Case report). Anestezi Dergisi, Cilt: 9 - Sayı: 1, 62–66. https://ajindex.com/articles/355361

References (18)

  1. Bella IR, Chad DA. Guillain-Barre syndrome. In: Irwin RS, Cerra FB, Rippe JM, (eds) Intensive Care Medicine, New York, Lippincott-Raven 1998: 2115-2122
  2. Bosch EP, Mitsumoto H. Disorders of peripheral nerves. In: Bradley WG, Darof RB, (eds) Neurology In Clinical Practise. The Neurological Disorders. Boston, Buterworth-Heineman 1996; 1720-1792
  3. Ropper AH. The Guillain-Barre syndrome. N Engl J Med 1992; 326: 1130-5
  4. Arnason BGW. Acute inflammatory demyelinating polyradi-culoneuropathy. In: Dyck PJ, Thomas PK, Griffin JW, et al (eds) Peripheral Neuropathy. Philadelphia, WB Saunders 1993;1437
  5. Hirayama K. Apheresis for neuromuscular diseases. Jpn J Apheresis 1995; 14:4-7, 6. Ropper AH, Kehne SM. Guillain-Barre syndrome: Management of respiratory failure. Neurology 1985; 35: 1662-8
  6. Rees J. Guillain-Barre syndrome. Clinical manifestations and directions for treatment. Drugs 1995; 49: 912-20
  7. Hund EF, Borel CD, Cornblath DR, Hanley DF, McKhann GM. Intensive management and treatment of severe Guillain-Barre syndrome. Crit Care Med 1993; 21:433-46
  8. Lichtenfeld P. Autonomic dysfunction in the Guillain-Barre syndrome. Am J Med 1971; 50: 772-6
  9. Huges RCA, Radlubowski M, Hufschimidt A. Treatment of acute inflammatory polyneuropaty. Ann Neurol 1981; 9(Suppl 1): 70
  10. Lang JD, Cook DJ, Hunt DL. Plasma exchange for Guillain-Barre syndrome: A systematic overwiev. J Gen Int Med 1994; 9(Suppl 2): 32
  11. Reimann PM, Mason PD. Plasmapheresis: Technique and complications. Intensive Care Med 1990;16: 3-10
  12. The Guillain Barre Syndrome Study Group. Plasmapheresis and acute Guillain-Barre syndrome. Neurology 1985; 35: 1096-104
  13. French Cooperative Group on Plasma Exchange in Guillain-Barre Syndrome: Efficiency of plasma exchange in Guillain-Barre syndrome: role of replacement fluids. Ann Neurol 1987; 22:753-61
  14. Farkkila M, Kinnunen E, Haapanen E, et al. Guillain-Barre syndrome: Quantitative measurement of plasma exchange therapy. Neurology 1987; 37: 837-40
  15. Greenwood RJ, Hughes RAC, Bowden AN, et al. Controlled trial of plasma exchange in acute inflammatory polyradiculo-neuropathy. Lancet 1984; 1: 877-9
  16. Osterman PO, Lundemo G, Pirskanen R, et al. Beneficial effects of plasma exchange in acute inflammatory polyradiculo-neuropathy. Lancet 1984; 1: 1296-8
  17. French Cooperative Group on Plasma Exchange in Guillain-Barre Syndrome: Plasma exchange in Guillain-Barre syndrome: one- year follow-up. Ann Neurol 1992; 32: 94-7
  18. Jimenez C